News

December 2011

Interview with Dr. Eduardo Anitua on Onda Cero radio station

Dr Eduardo Anitua interview on the radio station Onda Cero Vitoria for the recognition delivered on 16 December, by the College of Physicians of Alava (ICOMA).

During the interview, of 8 minutes aprox, ICOMA notes that this distinction gives the doctor for his work in "innovation in the practice of medicine and dissemination of knowledge."

In addition, Anitua recognizes the work of the professional staff that is part of BTI, and speaks of research in oral implantology and regenerative therapy by the research department of BTI.

December 2011

Interview with Dr. Eduardo Anitua in Spain National Radio

Interview with the Vitorian researcher Dr. Eduardo Anitua, Scientific Director of BTI Biotechnology Institute and President of the Eduardo Anitua Foundation for biomedical research at the Spain National Radio program "En días como hoy".

Eduardo Anitua´s research to regenerate tissues.

Eduardo Anitua Doctor in medicine and surgery and Stomatology specialist talks about his research to stimulate and accelerate tissue healing and bone regeneration. "We seek a total regeneration, so that, for example, 100% muscle perform", he explains. "Cells need information and that data, come from proteins of the own patients, which is what we study." In addition, advocates of the skeptics: "Whenever there is something new people think there´s a catch, but not, we are adapting biology, for example, to orthopaedics."

December 2011

The Official Medicine Association of Alava pays tribute to Dr. Eduardo Anitua and Mikel Sanchez

The Official Medicine Association of Alava (ICOMA) has paid tribute to Dr. Eduardo Anitua and Mikel Sánchez in recognition of their innovative activity in the medicine field and the disclosure of its knowledge. The ceremony has taken place during tha annual celebration of the Association.

December 2011

El Colegio de Medicos de Alava homenajeara a los doctores Eduardo Anitua y Mikel Sanchez en su fiesta anual_version_1.01_

El Colegio Oficial de Médicos de Álava (ICOMA) realizará el próximo 16 de diciembre un homenaje a los doctores vitorianos Eduardo Anitua y Mikel Sánchez por su innovación en el ejercicio de la medicina y la difusión del conocimiento. Este acto tendrá lugar durante la celebración de la fiesta anual que celebra el Colegio, en la que se reconoce a casi un centenar de médicos de la provincia.

El Dr. Anitua es fundador y director científico de BTI Biotechnology Institute, empresa de biomedicina y biotecnología de Vitoria-Gasteiz. Así mismo, es presidente de la Fundación Eduardo Anitua para la investigación en medicina regenerativa. El Dr. Mikel Sánchez es el jefe de la unidad de Cirugía Artroscópica de la clínica USP La Esperanza de Vitoria-Gasteiz.

Reconocimiento al Médico Solidario
El Colegio de Médicos de Álava también reconocerá la labor del Dr. Jesús Mª García Calleja otorgándole el premio al “Médico solidario” por su dedicación sanitaria en países menos favorecidos y en conflicto. Este médico alavés trabaja actualmente en el departamento de VIH de la Organización Mundial de la Salud (OMS), con la que ha recorrido países como Camerún, Liberia o Guinea Ecuatorial. Su labor en Médicos sin Fronteras le ha llevado además a prestar asistencia de urgencia a refugiados en Afganistan, Yemen, Sudan, Honduras y Zambia. El Dr. García Calleja continúa colegiado en Álava.

La fiesta del ICOMA tendrá lugar el próximo 16 de diciembre a partir de las 19.30h en el Museo Artium de Vitoria-Gasteiz.

December 2011

Interview with Dr Eduardo Anitua in Intereconomia Radio

Interview the Vitorian Eduardo Anitua, doctor in medicine and surgery, and dentistry specialist and researcher. Scientific Director of BTI Biotechnology Institute and President of the Eduardo Anitua Foundation for biomedical research, on the program "Capital, la bolsa y la vida" on the Spanish Intereconomia radio station.

December 2011

Round table CIC Network 10 Science Technology and Innovation

Exciting discussion about what is understood by science, technology and innovation. Manuel Martín Lomas, Eduardo Anitua, Nuria López de Gereñu and Javier Ormazabal participate and Jose M Mato moderates taking place at BTI.

The definition of science, technology and innovation is not unique and may change depending the training, profession, institution or company of the person who defines. The objective of this roundtable is to examine what we mean by science, technology and innovation, from different points of views. So Manuel Martín Lomas, CSIC research professor and scientific director of CIC biomaGUNE, Eduardo Anitua, CEO of BTI, Javier Ormazábal, President and CEO of Grupo Ormazabal, and Nuria López de Gereñu, general secretary of CONFEBASK where invited to participate.

November 2011

Dr. Eduardo Anitua receives the Personalities of the Year in recognition of his career

Vitoria, November 28, 2011. The doctor and researcher Eduardo Anitua, Scientific Director of BTI Biotechnology Institute and President of the Eduardo Anitua Foundation for biomedical research, has received the award "Personalities of the Year" awarded by the station Punto Radio Vitoria. The award, distinguishes him as "Vitorian of the Year" in recognition of his contribution to the medical society and patients.

"It is an honour for both me and for BTI to receive this award", says Eduardo Anitua. "Our motto has always been to have scientific research as a basis for facing the new challenges of modern medicine and transfer the results of the research to every possible aspect of medical practice, with the ultimate goal of improving patients’ quality of life", he adds.

The "Personality of the Year" awards are given annually to the most prominent personalities of Vitoria and Alava society and to the most prominent personalities at a national level in the fields of television, communication, humour and music.

Both Eduardo Anitua and BTI Biotechnology Institute have received numerous awards and recognitions for their outstanding career, such as the Prince of Asturias Award for Technological Innovation in 2007 or the recently received Lan Onari prize, awarded by the Basque Government last October.

Eduardo Anitua is the founder and the Scientific Director of BTI Biotechnology Institute, one of the leading companies in implantology and oral rehabilitation, and a world scientific leader in translational regenerative medicine, a pioneer in the development and therapeutic use of the Plasma Rich in Growth Factors, PRGF®-Endoret®, with 37 international patents to its credit.

September 2011

BTI Biotechnology Institute opens its doors to media

Yesterday, September 14, BTI Biotechnology threw its doors open to the media in order to explain the various areas of biomedicine in which it works, as well as to show off its facilities which, in the area of regenerative medicine and oral implantology, are among the most cutting-edge in Spain.

The event aroused considerable interest, and BTI was happy to welcome representatives from a dozen media organizations, including El País, EFE, Diario Médico, and Radio Nacional.

Juan Carlos Flores, Director of Strategy and Development at BTI, was tasked with introducing the company, its origins, its development, and how it has become one of Europe’s most respected companies in the oral implantology sector, as well as a world leader in the science of tissue regeneration through the use of autologous plasma rich in growth factors (PRGF®-Endoret®).

Afterwards, the journalists were invited to inspect BTI’s facilities at first hand, boasting technologically ground-breaking equipment. The journalists were specially interested in seeing not only the facilities in the R&D area, but also the operating rooms, the most modern and best-equipped in Spain, which Dr. Eduardo Anitua himself took time to show and explain to the visitors.

Next it was the turn of Gorka Orive, Head of the Regenerative Medicine Laboratory at BTI, who proceeded to give the assembled media a brief introduction to the topic of plasma rich in growth factors, early research efforts, the company’s investment in R&D&I, the many laboratory and clinical studies, as well as the different therapeutic applications for PRGF®-Endoret®, among others.

Finally, Dr. Anitua drew attention to the latest advances and the vast present and future therapeutic possibilities that have been opened up thanks to this innovative technique, after which he fielded questions from the members of the media.

September 2011

Plasma Rich in Growth Factors (PRGF.Endoret) used to treat King Juan Carlos I

Early this morning the King underwent an operation to relieve a painful Achilles tendon in his left leg. It was a minor operation requiring neither general anesthesia nor hospitalization. During the operation, the traumatologist Ángel Villamor used Plasma Rich in Growth Factor (PRGF®-Endoret®), a technology developed and patented by BTI Biotechnology Institute, to promote the regeneration and repair of the damaged tissues, as well as to hasten the recovery of the King’s heel.

By applying PRGF®-Endoret® it is possible to simulate and accelerate (by up to 40%) the physiological mechanisms of repair triggered spontaneously in all damaged tissues, whether as a result of injury, surgical treatment, or disease. With this method, the destroyed or damaged tissue is replaced by a natural process with fresh tissue, but in much less time than is the case with conventional treatments. All this from small concentrations of blood plasma obtained by centrifuging the patient’s own blood. As this treatment involves using the patient’s own plasma, there is never any question of an allergic reaction or of rejection of the treatment.

PRGF®-Endoret®, a technology that is 100% Spanish.

PRGF®-Endoret® technology first emerged in the late 1990s from the hand of the Basque medical stomatologist, Eduardo Anitua. Since then, Dr. Anitua has been working tirelessly to find possible therapeutic applications for growth factors for improving and speeding up the processes of healing in his patients in the aftermath of surgery.

After setting up his own research centre in Vitoria, BTI Biotechnology Institute, Dr. Anitua began using PRGF®-Endoret® in oral surgery as a means of regenerating the bone tissue around dental implants and so cut down on their consolidation time. But within a short time, and given the versatility of this technology, its application has spread to different areas of medicine such as ophthalmology, dermatology, cosmetic surgery, sports medicine, and traumatology.


The solution chosen by many sports personalities and celebrities is now within everyone’s reach.
Thanks to its excellent therapeutic results, backed up by countless clinical trials and scientific publications in internationally renowned journals, a large number of public personalities, celebrities, and ordinary citizens have benefited from PRGF®-Endoret®. Take the case of tennis ace Rafa Nadal or Barcelona football star Xavi Hernández – both have used this treatment on a number of occasions to speed their recovery from an and enable them to get back to competing as quickly as possible.

However, this therapeutic technique is not just a treatment for the rich and famous – its cost is not high and its benefits are well known. By now, several thousands of patients have been treated successfully with PRGF®-Endoret®.

February 2011

Round table about public and private collaboration at scientifical research.

CIC Network, science magazine promoted by the Cooperative of Research Centres (CIC) has recently hold a roundtable to discuss about research projects conducted jointly by the private and public sector.

This activity, which Network CIC organised regularly, is an excellent forum and framework for scientific discussion. In this occasion, the roundtable was hold at Eduardo Anitua Institute.

November 2010

BTI gets Institutional recognition for its commitment with the innovation

The firm commitment to scientific research and the acquisition of an advanced technological infrastructure have made Eduardo Anitua Institute a world reference center in oral implantology and regenerative therapies.

During the visit, the Basque Councillor and the General Secretary of the Basque Business Confederation (Confebask) could learn more about the latest technological developments made by BTI.

During the last years, the Company has strongly invested in innovation as a key factor for its development so, in that sense, the visit has meant recognition to its innovation capability and a an institutional support for BTI´s contribution to the technological improvement of the Basque Country.

October 2010

The World Anti Doping Agency (WADA) has withdrawn from the 2011 list of prohibited substances and methods the intramuscular treatment which includes PRGF

The World Anti-Doping Agency (WADA) has withdrawn from the 2011 list of prohibited substances and methods the intramuscular treatment known as PRP, which includes PRGF, the treatment with autologous growth factors (from the patient himself), developed by the Spanish doctors Eduardo Anitua and Mikel Sánchez.

This procedure, which greatly accelerates tissue regeneration times to allow an earlier return to sports, had been included by WADA in the 2010 list of prohibited substances and methods for use in muscular injuries, although it was allowed both for tendon and ligament injuries. Thanks to the mediation of the Spanish Olympic Committee (COE), the innovative treatment of the Spanish doctors Eduardo Anitua and Mikel Sánchez has been allowed again by the World Anti-Doping Agency.

Over the period of one year, the Spanish doctors have been providing scientific evidence to demonstrate that their innovative injury treatment does not result in any doping. The evidence, in form of extensive documentation that was first submitted to the Spanish Anti-Doping Agency, then to the Medical Commission of the International Olympic Committee and finally to the World Anti-Doping Agency, convinced the members of the WADA that the pioneering treatment of the two Spanish doctors is not performance enhancing.

June 2010

Vitoria welcomes one of the most important Scientific Symposium on Regenerative Medicine

The first edition of the International Symposium on Translational Regenerative Medicine took place on October 31st 2009. this is the first event of this kind organized by Eduardo Anitua Foundation focuses on the application of new regenerative therapies for specific diseases or specific patient groups.